Granisetron
GRANISETRON HYDROCHLORIDE
- Strength
- 1 mg/mL
- Form
- Injection, Solution
- Class
- Serotonin-3 Receptor Antagonist
Fresenius Kabi USA, LLC
Listed by Bionpharma Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Serotonin-3 Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 69452-350 |
| FDA application | ANDA078678 |
| RxNorm concept | 310599 |
| Package sizes listed | 3 |
| Marketed since | February 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
GRANISETRON HYDROCHLORIDE
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Eugia US LLC
Eugia US LLC
Hikma Pharmaceuticals USA Inc.
Breckenridge Pharmaceutical, Inc.
Mylan Institutional LLC
Natco Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.